Selected research
Market Analysis & Forecast
Global Lansoprazole Injection Market Analysis and Forecast 2026-2032
Market perspective
The global Lansoprazole Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Lansoprazole Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Lansoprazole Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Lansoprazole Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Lansoprazole Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Lansoprazole Injection include Yuekang Pharmaceutical, Takeda, Luoxin Pharmaceutical, Jiangsu Aosaikang Pharmaceutical, Chengdu Baiyu Pharmaceutical and Maya Biotech, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Lansoprazole Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Lansoprazole Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Lansoprazole Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Lansoprazole Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Lansoprazole Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Lansoprazole Injection sales, projected growth trends, production technology, application and end-user industry.
Lansoprazole Injection Segment by Company
Yuekang Pharmaceutical
Takeda
Luoxin Pharmaceutical
Jiangsu Aosaikang Pharmaceutical
Chengdu Baiyu Pharmaceutical
Maya Biotech
Lansoprazole Injection Segment by Type
Vial Type
Ampule Type
Lansoprazole Injection Segment by Application
Male
Female
Lansoprazole Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lansoprazole Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lansoprazole Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lansoprazole Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Lansoprazole Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Lansoprazole Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lansoprazole Injection sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Vial Type
- Ampule Type
Applications
- Male
- Female
Companies covered
- Yuekang Pharmaceutical
- Takeda
- Luoxin Pharmaceutical
- Jiangsu Aosaikang Pharmaceutical
- Chengdu Baiyu Pharmaceutical
- Maya Biotech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Lansoprazole Injection Market by Type
- 1.2.1 Global Lansoprazole Injection Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Vial Type
- 1.2.3 Ampule Type
- 1.3 Lansoprazole Injection Market by Application
- 1.3.1 Global Lansoprazole Injection Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Male
- 1.3.3 Female
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Lansoprazole Injection Market Dynamics
- 2.1 Lansoprazole Injection Industry Trends
- 2.2 Lansoprazole Injection Industry Drivers
- 2.3 Lansoprazole Injection Industry Opportunities and Challenges
- 2.4 Lansoprazole Injection Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Lansoprazole Injection Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Lansoprazole Injection Revenue by Region
- 3.2.1 Global Lansoprazole Injection Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Lansoprazole Injection Revenue by Region (2021-2026)
- 3.2.3 Global Lansoprazole Injection Revenue by Region (2027-2032)
- 3.2.4 Global Lansoprazole Injection Revenue Market Share by Region (2021-2032)
- 3.3 Global Lansoprazole Injection Sales Estimates and Forecasts 2021-2032
- 3.4 Global Lansoprazole Injection Sales by Region
- 3.4.1 Global Lansoprazole Injection Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Lansoprazole Injection Sales by Region (2021-2026)
- 3.4.3 Global Lansoprazole Injection Sales by Region (2027-2032)
- 3.4.4 Global Lansoprazole Injection Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Lansoprazole Injection Revenue by Manufacturers
- 4.1.1 Global Lansoprazole Injection Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Lansoprazole Injection Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Lansoprazole Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Lansoprazole Injection Sales by Manufacturers
- 4.2.1 Global Lansoprazole Injection Sales by Manufacturers (2021-2026)
- 4.2.2 Global Lansoprazole Injection Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Lansoprazole Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Lansoprazole Injection Sales Price by Manufacturers (2021-2026)
- 4.4 Global Lansoprazole Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Lansoprazole Injection Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Lansoprazole Injection Manufacturers, Product Type & Application
- 4.7 Global Lansoprazole Injection Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Lansoprazole Injection Market CR5 and HHI
- 4.8.2 2025 Lansoprazole Injection Tier 1, Tier 2, and Tier 3
5 Lansoprazole Injection Market by Type
- 5.1 Global Lansoprazole Injection Revenue by Type
- 5.1.1 Global Lansoprazole Injection Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Lansoprazole Injection Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Lansoprazole Injection Revenue Market Share by Type (2021-2032)
- 5.2 Global Lansoprazole Injection Sales by Type
- 5.2.1 Global Lansoprazole Injection Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Lansoprazole Injection Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Lansoprazole Injection Sales Market Share by Type (2021-2032)
- 5.3 Global Lansoprazole Injection Price by Type
6 Lansoprazole Injection Market by Application
- 6.1 Global Lansoprazole Injection Revenue by Application
- 6.1.1 Global Lansoprazole Injection Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Lansoprazole Injection Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Lansoprazole Injection Revenue Market Share by Application (2021-2032)
- 6.2 Global Lansoprazole Injection Sales by Application
- 6.2.1 Global Lansoprazole Injection Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Lansoprazole Injection Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Lansoprazole Injection Sales Market Share by Application (2021-2032)
- 6.3 Global Lansoprazole Injection Price by Application
7 Company Profiles
- 7.1 Yuekang Pharmaceutical
- 7.1.1 Yuekang Pharmaceutical Company Information
- 7.1.2 Yuekang Pharmaceutical Business Overview
- 7.1.3 Yuekang Pharmaceutical Lansoprazole Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Yuekang Pharmaceutical Lansoprazole Injection Product Portfolio
- 7.1.5 Yuekang Pharmaceutical Recent Developments
- 7.2 Takeda
- 7.2.1 Takeda Company Information
- 7.2.2 Takeda Business Overview
- 7.2.3 Takeda Lansoprazole Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Takeda Lansoprazole Injection Product Portfolio
- 7.2.5 Takeda Recent Developments
- 7.3 Luoxin Pharmaceutical
- 7.3.1 Luoxin Pharmaceutical Company Information
- 7.3.2 Luoxin Pharmaceutical Business Overview
- 7.3.3 Luoxin Pharmaceutical Lansoprazole Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Luoxin Pharmaceutical Lansoprazole Injection Product Portfolio
- 7.3.5 Luoxin Pharmaceutical Recent Developments
- 7.4 Jiangsu Aosaikang Pharmaceutical
- 7.4.1 Jiangsu Aosaikang Pharmaceutical Company Information
- 7.4.2 Jiangsu Aosaikang Pharmaceutical Business Overview
- 7.4.3 Jiangsu Aosaikang Pharmaceutical Lansoprazole Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Jiangsu Aosaikang Pharmaceutical Lansoprazole Injection Product Portfolio
- 7.4.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
- 7.5 Chengdu Baiyu Pharmaceutical
- 7.5.1 Chengdu Baiyu Pharmaceutical Company Information
- 7.5.2 Chengdu Baiyu Pharmaceutical Business Overview
- 7.5.3 Chengdu Baiyu Pharmaceutical Lansoprazole Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Chengdu Baiyu Pharmaceutical Lansoprazole Injection Product Portfolio
- 7.5.5 Chengdu Baiyu Pharmaceutical Recent Developments
- 7.6 Maya Biotech
- 7.6.1 Maya Biotech Company Information
- 7.6.2 Maya Biotech Business Overview
- 7.6.3 Maya Biotech Lansoprazole Injection Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Maya Biotech Lansoprazole Injection Product Portfolio
- 7.6.5 Maya Biotech Recent Developments
8 North America
- 8.1 North America Lansoprazole Injection Market Size by Type
- 8.1.1 North America Lansoprazole Injection Revenue by Type (2021-2032)
- 8.1.2 North America Lansoprazole Injection Sales by Type (2021-2032)
- 8.1.3 North America Lansoprazole Injection Price by Type (2021-2032)
- 8.2 North America Lansoprazole Injection Market Size by Application
- 8.2.1 North America Lansoprazole Injection Revenue by Application (2021-2032)
- 8.2.2 North America Lansoprazole Injection Sales by Application (2021-2032)
- 8.2.3 North America Lansoprazole Injection Price by Application (2021-2032)
- 8.3 North America Lansoprazole Injection Market Size by Country
- 8.3.1 North America Lansoprazole Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Lansoprazole Injection Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Lansoprazole Injection Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Lansoprazole Injection Market Size by Type
- 9.1.1 Europe Lansoprazole Injection Revenue by Type (2021-2032)
- 9.1.2 Europe Lansoprazole Injection Sales by Type (2021-2032)
- 9.1.3 Europe Lansoprazole Injection Price by Type (2021-2032)
- 9.2 Europe Lansoprazole Injection Market Size by Application
- 9.2.1 Europe Lansoprazole Injection Revenue by Application (2021-2032)
- 9.2.2 Europe Lansoprazole Injection Sales by Application (2021-2032)
- 9.2.3 Europe Lansoprazole Injection Price by Application (2021-2032)
- 9.3 Europe Lansoprazole Injection Market Size by Country
- 9.3.1 Europe Lansoprazole Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Lansoprazole Injection Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Lansoprazole Injection Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Lansoprazole Injection Market Size by Type
- 10.1.1 China Lansoprazole Injection Revenue by Type (2021-2032)
- 10.1.2 China Lansoprazole Injection Sales by Type (2021-2032)
- 10.1.3 China Lansoprazole Injection Price by Type (2021-2032)
- 10.2 China Lansoprazole Injection Market Size by Application
- 10.2.1 China Lansoprazole Injection Revenue by Application (2021-2032)
- 10.2.2 China Lansoprazole Injection Sales by Application (2021-2032)
- 10.2.3 China Lansoprazole Injection Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Lansoprazole Injection Market Size by Type
- 11.1.1 Asia Lansoprazole Injection Revenue by Type (2021-2032)
- 11.1.2 Asia Lansoprazole Injection Sales by Type (2021-2032)
- 11.1.3 Asia Lansoprazole Injection Price by Type (2021-2032)
- 11.2 Asia Lansoprazole Injection Market Size by Application
- 11.2.1 Asia Lansoprazole Injection Revenue by Application (2021-2032)
- 11.2.2 Asia Lansoprazole Injection Sales by Application (2021-2032)
- 11.2.3 Asia Lansoprazole Injection Price by Application (2021-2032)
- 11.3 Asia Lansoprazole Injection Market Size by Country
- 11.3.1 Asia Lansoprazole Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Lansoprazole Injection Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Lansoprazole Injection Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Lansoprazole Injection Market Size by Type
- 12.1.1 SAMEA Lansoprazole Injection Revenue by Type (2021-2032)
- 12.1.2 SAMEA Lansoprazole Injection Sales by Type (2021-2032)
- 12.1.3 SAMEA Lansoprazole Injection Price by Type (2021-2032)
- 12.2 SAMEA Lansoprazole Injection Market Size by Application
- 12.2.1 SAMEA Lansoprazole Injection Revenue by Application (2021-2032)
- 12.2.2 SAMEA Lansoprazole Injection Sales by Application (2021-2032)
- 12.2.3 SAMEA Lansoprazole Injection Price by Application (2021-2032)
- 12.3 SAMEA Lansoprazole Injection Market Size by Country
- 12.3.1 SAMEA Lansoprazole Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Lansoprazole Injection Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Lansoprazole Injection Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Lansoprazole Injection Value Chain Analysis
- 13.1.1 Lansoprazole Injection Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Lansoprazole Injection Production Mode & Process
- 13.2 Lansoprazole Injection Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Lansoprazole Injection Distributors
- 13.2.3 Lansoprazole Injection Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst